1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Country/Region, 2017, 2022 & 2028 2.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type 2.2.1 Diagnostic 2.2.2 Therapeutic 2.3 Nuclear Medicine & Radiopharmaceuticals Sales by Type 2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022) 2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Type (2017-2022) 2.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2017-2022) 2.4 Nuclear Medicine & Radiopharmaceuticals Segment by Application 2.4.1 Oncology 2.4.2 Thyroid 2.4.3 Cardiology 2.4.4 Others 2.5 Nuclear Medicine & Radiopharmaceuticals Sales by Application 2.5.1 Global Nuclear Medicine & Radiopharmaceuticals Sale Market Share by Application (2017-2022) 2.5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Application (2017-2022) 2.5.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2017-2022) 3 Global Nuclear Medicine & Radiopharmaceuticals by Company 3.1 Global Nuclear Medicine & Radiopharmaceuticals Breakdown Data by Company 3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Company (2020-2022) 3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2020-2022) 3.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Company (2020-2022) 3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2020-2022) 3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2020-2022) 3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company 3.4 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Location Distribution 3.4.2 Players Nuclear Medicine & Radiopharmaceuticals Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Nuclear Medicine & Radiopharmaceuticals by Geographic Region 4.1 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Geographic Region (2017-2022) 4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Geographic Region 4.2 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Country/Region (2017-2022) 4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Country/Region (2017-2022) 4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Country/Region 4.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales Growth 4.4 APAC Nuclear Medicine & Radiopharmaceuticals Sales Growth 4.5 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth 4.6 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth 5 Americas 5.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country 5.1.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) 5.1.2 Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) 5.2 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type 5.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region 6.1.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2022) 6.1.2 APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2022) 6.2 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type 6.3 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Nuclear Medicine & Radiopharmaceuticals by Country 7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) 7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) 7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type 7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals by Country 8.1.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) 8.1.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) 8.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type 8.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals 10.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals 10.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Nuclear Medicine & Radiopharmaceuticals Distributors 11.3 Nuclear Medicine & Radiopharmaceuticals Customer 12 World Forecast Review for Nuclear Medicine & Radiopharmaceuticals by Geographic Region 12.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Region 12.1.1 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Region (2023-2028) 12.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Type 12.7 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Application 13 Key Players Analysis 13.1 China Isotope & Radiation 13.1.1 China Isotope & Radiation Company Information 13.1.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offered 13.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 China Isotope & Radiation Main Business Overview 13.1.5 China Isotope & Radiation Latest Developments 13.2 Dongcheng 13.2.1 Dongcheng Company Information 13.2.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offered 13.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Dongcheng Main Business Overview 13.2.5 Dongcheng Latest Developments 13.3 Jaco 13.3.1 Jaco Company Information 13.3.2 Jaco Nuclear Medicine & Radiopharmaceuticals Product Offered 13.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Jaco Main Business Overview 13.3.5 Jaco Latest Developments 13.4 Ciaeriar 13.4.1 Ciaeriar Company Information 13.4.2 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offered 13.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Ciaeriar Main Business Overview 13.4.5 Ciaeriar Latest Developments 13.5 Advanced Molecular-imaging Solution 13.5.1 Advanced Molecular-imaging Solution Company Information 13.5.2 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offered 13.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Advanced Molecular-imaging Solution Main Business Overview 13.5.5 Advanced Molecular-imaging Solution Latest Developments 13.6 Shanghai Atom Kexing 13.6.1 Shanghai Atom Kexing Company Information 13.6.2 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offered 13.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Shanghai Atom Kexing Main Business Overview 13.6.5 Shanghai Atom Kexing Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Diagnostic Table 4. Major Players of Therapeutic Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units) Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022) Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2022) & ($ million) Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2017-2022) Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2017-2022) & (US$/Unit) Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units) Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022) Table 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2022) Table 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2017-2022) Table 14. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2017-2022) & (US$/Unit) Table 15. Global Nuclear Medicine & Radiopharmaceuticals Sales by Company (2020-2022) & (K Units) Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2020-2022) Table 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2020-2022) ($ Millions) Table 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2020-2022) Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company (2020-2022) & (US$/Unit) Table 20. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution and Sales Area Table 21. Players Nuclear Medicine & Radiopharmaceuticals Products Offered Table 22. Nuclear Medicine & Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Region (2017-2022) & (K Units) Table 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Geographic Region (2017-2022) Table 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales by Country/Region (2017-2022) & (K Units) Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country/Region (2017-2022) Table 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units) Table 34. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022) Table 35. Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022) Table 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units) Table 38. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022) Table 39. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units) Table 40. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022) Table 41. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2022) & (K Units) Table 42. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2017-2022) Table 43. APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2017-2022) Table 45. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units) Table 46. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022) Table 47. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units) Table 48. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022) Table 49. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units) Table 50. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022) Table 51. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022) Table 53. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units) Table 54. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022) Table 55. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units) Table 56. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units) Table 58. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units) Table 62. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units) Table 64. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Nuclear Medicine & Radiopharmaceuticals Table 66. Key Market Challenges & Risks of Nuclear Medicine & Radiopharmaceuticals Table 67. Key Industry Trends of Nuclear Medicine & Radiopharmaceuticals Table 68. Nuclear Medicine & Radiopharmaceuticals Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Nuclear Medicine & Radiopharmaceuticals Distributors List Table 71. Nuclear Medicine & Radiopharmaceuticals Customer List Table 72. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units) Table 73. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Forecast by Region Table 74. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units) Table 77. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units) Table 79. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units) Table 81. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units) Table 83. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Units) Table 85. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028) Table 86. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Units) Table 89. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028) Table 90. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028) Table 92. China Isotope & Radiation Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors Table 93. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offered Table 94. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 95. China Isotope & Radiation Main Business Table 96. China Isotope & Radiation Latest Developments Table 97. Dongcheng Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors Table 98. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offered Table 99. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 100. Dongcheng Main Business Table 101. Dongcheng Latest Developments Table 102. Jaco Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors Table 103. Jaco Nuclear Medicine & Radiopharmaceuticals Product Offered Table 104. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 105. Jaco Main Business Table 106. Jaco Latest Developments Table 107. Ciaeriar Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors Table 108. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offered Table 109. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 110. Ciaeriar Main Business Table 111. Ciaeriar Latest Developments Table 112. Advanced Molecular-imaging Solution Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors Table 113. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offered Table 114. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 115. Advanced Molecular-imaging Solution Main Business Table 116. Advanced Molecular-imaging Solution Latest Developments Table 117. Shanghai Atom Kexing Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors Table 118. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offered Table 119. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 120. Shanghai Atom Kexing Main Business Table 121. Shanghai Atom Kexing Latest Developments List of Figures Figure 1. Picture of Nuclear Medicine & Radiopharmaceuticals Figure 2. Nuclear Medicine & Radiopharmaceuticals Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2017-2028 (K Units) Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Diagnostic Figure 10. Product Picture of Therapeutic Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2021 Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2017-2022) Figure 13. Nuclear Medicine & Radiopharmaceuticals Consumed in Oncology Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market: Oncology (2017-2022) & (K Units) Figure 15. Nuclear Medicine & Radiopharmaceuticals Consumed in Thyroid Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Market: Thyroid (2017-2022) & (K Units) Figure 17. Nuclear Medicine & Radiopharmaceuticals Consumed in Cardiology Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Market: Cardiology (2017-2022) & (K Units) Figure 19. Nuclear Medicine & Radiopharmaceuticals Consumed in Others Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Market: Others (2017-2022) & (K Units) Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022) Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2021 Figure 23. Nuclear Medicine & Radiopharmaceuticals Revenue Market by Company in 2021 ($ Million) Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company in 2021 Figure 25. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Geographic Region (2017-2022) Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region in 2021 Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2017-2022) Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region in 2021 Figure 29. Americas Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units) Figure 30. Americas Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions) Figure 31. APAC Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units) Figure 32. APAC Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions) Figure 33. Europe Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units) Figure 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions) Figure 35. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units) Figure 36. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions) Figure 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021 Figure 38. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021 Figure 39. United States Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 40. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 41. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 42. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 43. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2021 Figure 44. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2021 Figure 45. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 46. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 47. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 48. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 49. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 50. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 51. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021 Figure 52. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021 Figure 53. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 54. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 55. UK Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 56. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 57. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 58. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021 Figure 59. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021 Figure 60. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 61. South Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 62. Israel Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 63. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 64. GCC Country Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions) Figure 65. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2021 Figure 66. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals Figure 67. Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals Figure 68. Channels of Distribution Figure 69. Distributors Profiles